DOI QR코드

DOI QR Code

Multilevel Analysis of the Relationship Between Prescribing Institutions and Medication Adherence Among Patients With Hypertension and Diabetes in Korea

  • Haryeom Ghang (Health Insurance Research Institute, National Health Insurance Service) ;
  • Juhyang Lee (Health Insurance Research Institute, National Health Insurance Service)
  • Received : 2023.06.01
  • Accepted : 2023.09.19
  • Published : 2023.11.30

Abstract

Objectives: This study investigated the relationship between prescribing institutions and medication adherence among patients newly diagnosed with hypertension and diabetes. Methods: This study investigated patients with new prescriptions for hypertension and diabetes in Korea in 2019 with using data collected from general health screenings. A multilevel logistic regression model was applied to explore the relationship between patients' first prescribing institution and their medication adherence, defined as a medication possession ratio (MPR) over 80%. Results: The overall adherence rates were 53.7% and 56.0% among patients with hypertension and diabetes, respectively. The intra-class correlation coefficients were 13.2% for hypertension and 13.8% for diabetes (p<0.001), implying that the first prescribing institution had a significant role in medication adherence. With clinics as the reference group, all other types of hospitals showed an odds ratio (OR) less than 1.00, with the lowest for tertiary hospitals (OR, 0.30 for hypertension; 0.45 for diabetes), and the next lowest in health screening specialized clinics (OR, 0.51 for hypertension; 0.46 for diabetes). Among individual-level variables, female sex, older age, higher insurance premium level, and residing in cities were positively associated with adherence in both the hypertension and diabetes samples. Conclusions: This study showed that the prescribing institution had a significant relationship with medication adherence. When the first prescribing institution was a clinic, newly diagnosed patients were more likely to adhere to their medication. These results highlight the important role played by primary care institutions in managing mild chronic diseases.

Keywords

References

  1. World Health Organization. Noncommunicable diseases; 2023 [cited 2023 May 22]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
  2. Korea Disease Control and Prevention Agency. 2022 Chronic disease fact book. Cheongju: Korea Disease Control and Prevention Agency; 2022, p. 6 (Korean).
  3. National Health Insurance Service, Health Insurance Review and Assessment Service. 2021 National health insurance statistical yearbook. Wonju: National Health Insurance Service, Health Insurance Review and Assessment Service; 2022, p. 22 (Korean).
  4. Lee EK. Factors associated with hypertension control in Korean adults: the fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2). J Korean Data Anal Soc 2013;15(6):3203-3217 (Korean).
  5. Han JO, Yim J, Im JS, Lee HY, Park JH, Oh DK. The effects of adherence and hypertension control on complication among newly diagnosed hypertension patients. Health Policy Manag 2015;25(2):90-96 (Korean). https://doi.org/10.4332/KJHPA.2015.25.2.90
  6. Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther 2011;33(1):74-109. https://doi.org/10.1016/j.clinthera.2011.01.019
  7. Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 2012;35(6):1279-1284. https://doi.org/10.2337/dc11-1277
  8. McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S. Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol. BMJ Open 2016;6(2):e010469.
  9. Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, Axon RN, Zhao Y, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care 2012;35(12):2533-2359.
  10. Kim SO. Medication adherence of elderly with hypertension and/or diabetes-mellitus and its' influencing factors. Korean J Clin Pharm 2011;21(2):81-89 (Korean).
  11. Lee MJ, Kang HK, Seo BJ. Correlation between outpatient's medical adherence and national insurance types in the type 2 diabetes mellitus. J Converg Inf Technol 2018;8(4):9-14 (Korean).
  12. Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol 2008;128(3):392-398. https://doi.org/10.1016/j.ijcard.2007.04.114
  13. Yoon SJ. The relationships of health literacy, medication adherence and self-care performance of diabetes mellitus patients. Health Nurs 2017;29(1):27-38 (Korean).
  14. Kim S, Jang S. Influence of multiple health risk behaviors of hypertension / diabetes patients on drug adherence. J Korean Acad Manag Care Pharm 2019;7(2):75-85 (Korean).
  15. Bae MS, Song H. Effect of primary care based chronic disease management program provision characteristics on medication adherence in hypertensive and diabetic patients: focusing on the implication for operation. J Korean Public Health Assoc 2021;47(3):21-31 (Korean).
  16. Han EB, Kim SJ, Choi HC, Kwon OD, Cho B. Impact of residential area on antihypertensive medication adhrence in Seoul, Korea. Korean J Fam Pract 2021;11(4):272-279 (Korean). https://doi.org/10.21215/kjfp.2021.11.4.272
  17. Sharma KP, Taylor TN. Pharmacy effect on adherence to antidiabetic medications. Med Care 2012;50(8):685-691. https://doi.org/10.1097/MLR.0b013e318249d800
  18. Lee SM, Ghang H, Lee SH, Kim DW, Kim SJ, Kim SY, et al. Study on the performance monitoring of national health screening: Health Insurance Research Institute (NHIS).Sejong: Ministry of Health and Welfare; 2022, p.77 (Korean).
  19. Guo G, Zhao H. Multilevel modeling for binary data. Ann Rev Sociol 2000;26(1):441-462. https://doi.org/10.1146/annurev.soc.26.1.441
  20. Austin PC, Merlo J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat Med 2017;36(20):3257-3277. https://doi.org/10.1002/sim.7336
  21. Lee H, Noh S. Advanced statistical analysis: theory and practice. 2nd ed. Goyang: Moonwoosa; 2013, p. 445 (Korean).
  22. Kim TE. Evaluation of the national health screening program of Korea. Seoul: National Assembly Budget Office; 2021, p. 77-80 (Korean).
  23. Pedan A, Varasteh L, Schneeweiss S. Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. J Manag Care Pharm 2007;13(6):487-496. https://doi.org/10.18553/jmcp.2007.13.6.487
  24. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007;298(1):61-69. https://doi.org/10.1001/jama.298.1.61
  25. Roblin DW, Platt R, Goodman MJ, Hsu J, Nelson WW, Smith DH, et al. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care 2005;43(10):951-959. https://doi.org/10.1097/01.mlr.0000178216.23514.b7
  26. US Centers for Medicare & Medicaid Services. Copayment [cited 2023 May 29]. Available from: https://www.healthcare.gov/glossary/co-payment/.
  27. Wandless I, Mucklow JC, Smith A, Prudham D. Compliance with prescribed medicines: a study of elderly patients in the community. J R Coll Gen Pract 1979;29(204):391-396.
  28. National Health Insurance Service. 2019 National health screening statistical yearbook. Wonju: National Health Insurance Service; 2020, p. 26 (Korean).
  29. Ministry of Health and Welfare. Announcement of region selection (5th) for primary care based chronic disease management [cited 2023 May 29]. Available from: https://www.mohw.go.kr/react/al/sal0101vw.jsp?PAR_MENU_ID=04&MENU_ID=040102&CONT_SEQ=363954 (Korean).